Drug & medication recalls Moderate risk

NEOGEN-D in each tsp recalled over manufacturing violations

Recall date
June 21, 2019
Source
U.S. Food & Drug Administration (FDA) — enforcement report
Official notice title
Pharma-Natural Inc. recalls NEOGEN-D (Dextromethorphan HBr, 30 mg; Guaifenesin, 200 mg; Phenylephrine HCl, 7.5 mg) in each 5 mL tsp, Raspberry Flav…
Recall number
D-1506-2019
FDA classification
Class II
Brand / firm
Pharma-Natural Inc.
Sold / distributed
Consignees in FL and TX who may have further distributed Nationwide in the USA and Puerto Rico.

Why it was recalled

CGMP Deviations: products were manufactured with lack of process validation, cleaning validation, stability studies, and other current good manufacturing practice violations.

Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What was recalled

NEOGEN-D (Dextromethorphan HBr, 30 mg; Guaifenesin, 200 mg; Phenylephrine HCl, 7.5 mg) in each 5 mL tsp, Raspberry Flavor, 16 fl oz (473 mL) bottle, Manufactured in the USA for Kramer Novis, San Juan, PR 00917, NDC 52083-699-16.

Get recall alerts

Free email alert whenever Pharma-Natural Inc. has a new recall — straight from official government data. Unsubscribe anytime.

More recalls from: Pharma-Natural Inc.